IA has never been tasked to have a outlook towards R&D. You want it have a outlook, fine good, maybe personally I agree but what of it?rohitvats wrote: Nobody underestimates the role and position of MOD in the whole set-up...but that is not an execuse to absolve IA of its inherent short-comings especially with respect to the outlook towards R&D.
They are not responsible to me or you. They are responsible to MoD. What does MoD want from them?
I do not think what the good general says supports your claim. He mentions ways in which IA and IN are different and IN has different approach.Oh!!! It does...why are you acting so surprise here? You laid the blame on the foot steps of MOD? The good General amply clarifies that the problem is with IA and does not stem from outside parameters.
Yes we know and agree. We also know why and how.
The good general wants it solved by upgrading IAs role and adding IN level features (in context of R&D) that decision however has been and will be MoDs (and I have discussed that before in other thread) -- basically I dont think what the good general wants will happen, the solution has to be slightly different.
If you want IA to have R&D directorates like IN has, it has to be a MoD decision. Without those, IA can not do what you want them to do.And oh! how is MOD involved?
You can look up the MoD website which I am tired of posting which lays out the relative responsibilities etc. Also because I have known how MoD works in these matters first hand.Because your highness says so? How about subjecting yourself to exacting standard of providing proof of MOD deciding how the trials are to be conducted and scheduled?
That would be fine too.Or am I supposed to believe this like the other argument of MOD+GOI responsible for lack of Arjun induction - because there is no proof to contrary?
If it has cleared why do the AUCRT? Of course it did not clear all parameters of evaluation.Do you know what AUCRT is? Before Arjun could have been subjected to AUCRT, it would have cleared all the parameters of evaluation?
It only cleared development trials.
No IA only gave initial clearance and the purchase was taken after AUCRT.So, what gives? And how does that negate the fact that IA recco the acquisition of T-90 without trialing them in India?
In contrast 124 Arjuns were purchase before AUCRT. The IA had to order 124 otherwise AUCRT could not happen.
That is called partnership which IA has shown.